Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production
NCT02747602 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2016-10-28
Summary
To compare serum ketone body (i.e., total ketones and β-hydroxybutyrate) levels after administration of AC-1204 versus caprylic triglyceride (CT) oil, both after a standard breakfast.
To evaluate the effect of a high fat diet on serum ketone body levels after administration of CT oil with a high fat breakfast versus a standard breakfast.
Conditions
- Healthy
Interventions
- DRUG
-
AC-1204
40 g (120 mL) AC-1204 administered 30 minutes after the start of a standard breakfast.
- DRUG
-
caprylic triglyceride oil (standard breakfast)
20 g CT oil (21 mL) administered 30 minutes after the start of a standard breakfast.
- DRUG
-
caprylic triglyceride oil (high fat breakfast)
20 g CT oil (21 mL) administered 30 minutes after the start of a high fat breakfast.
Sponsors & Collaborators
-
Celerion
collaborator INDUSTRY -
Cerecin
lead INDUSTRY
Principal Investigators
-
Geri Poss, MD · Celerion
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2016-05-31
- Completion
- 2016-10-31
Countries
- United States
Study Locations
More Related Trials
-
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
NCT05713799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
NCT05761301 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
NCT01968720 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
NCT03095807 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
NCT07140939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
NCT04407234 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
NCT05712876 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3457263 in Obese Participants
NCT05582096 ·Status: COMPLETED ·Phase: PHASE1
-
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
NCT01032889 ·Status: COMPLETED ·Phase: PHASE2
-
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
NCT03015207 ·Status: COMPLETED ·Phase: PHASE1
-
A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers
NCT00509132 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal
NCT00851747 ·Status: TERMINATED ·Phase: NA
-
Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
NCT02300844 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
NCT04081337 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
NCT05970640 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
NCT05822544 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
NCT05234736 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
NCT05282446 ·Status: COMPLETED ·Phase: PHASE1
-
Study Exploring the Supportive Effect of Acarbose in Weight Management
NCT05934110 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion
NCT07097987 ·Status: COMPLETED ·Phase: NA
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
NCT04897412 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
NCT04699669 ·Status: COMPLETED ·Phase: PHASE1